Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2007 | 1 |
2012 | 1 |
2021 | 1 |
2022 | 1 |
2023 | 1 |
2024 | 1 |
Search Results
6 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
Did you mean
pezza m
(67 results)?
Intraocular Pressure-Related Events After Anti-Vascular Endothelial Growth Factor Therapy for Macular Edema Due to Central Retinal Vein Occlusion or Hemiretinal Vein Occlusion: SCORE2 Report 16 on a Secondary Analysis of a Randomized Clinical Trial.
JAMA Ophthalmol. 2021 Dec 1;139(12):1285-1291. doi: 10.1001/jamaophthalmol.2021.4395.
JAMA Ophthalmol. 2021.
PMID: 34709363
Free PMC article.
Clinical Trial.
Cost-Utility Comparison of Bevacizumab and Aflibercept in the Treatment of Central or Hemiretinal Vein Occlusion in the SCORE2 Trial.
Kymes SM, Oden NL, VanVeldhuisen PC, Scott IU, Ip MS, Blodi BA, King J; SCORE2 Investigator Group.
Kymes SM, et al.
JAMA Ophthalmol. 2023 Jun 1;141(6):554-561. doi: 10.1001/jamaophthalmol.2023.1463.
JAMA Ophthalmol. 2023.
PMID: 37166820
Free PMC article.
Item in Clipboard
Baseline Characteristics and Outcomes After Anti-Vascular Endothelial Growth Factor Therapy for Macular Edema in Participants With Hemiretinal Vein Occlusion Compared With Participants With Central Retinal Vein Occlusion: Study of Comparative Treatments for Retinal Vein Occlusion 2 (SCORE2) Report 18.
Scott IU, Oden NL, VanVeldhuisen PC, Ip MS, Blodi BA; SCORE2 Study Investigator Group.
Scott IU, et al.
JAMA Ophthalmol. 2022 May 1;140(5):458-464. doi: 10.1001/jamaophthalmol.2022.0352.
JAMA Ophthalmol. 2022.
PMID: 35323843
Free PMC article.
Clinical Trial.
Item in Clipboard
Intravitreal aflibercept 8 mg in diabetic macular oedema (PHOTON): 48-week results from a randomised, double-masked, non-inferiority, phase 2/3 trial.
Brown DM, Boyer DS, Do DV, Wykoff CC, Sakamoto T, Win P, Joshi S, Salehi-Had H, Seres A, Berliner AJ, Leal S, Vitti R, Chu KW, Reed K, Rao R, Cheng Y, Sun W, Voronca D, Bhore R, Schmidt-Ott U, Schmelter T, Schulze A, Zhang X, Hirshberg B, Yancopoulos GD, Sivaprasad S; PHOTON Investigators.
Brown DM, et al.
Lancet. 2024 Mar 23;403(10432):1153-1163. doi: 10.1016/S0140-6736(23)02577-1. Epub 2024 Mar 7.
Lancet. 2024.
PMID: 38461843
Clinical Trial.
Item in Clipboard
Risk of non-arteritic anterior ischaemic optic neuropathy (NAION) after cataract extraction in the fellow eye of patients with prior unilateral NAION.
Lam BL, Jabaly-Habib H, Al-Sheikh N, Pezda M, Guirgis MF, Feuer WJ, McCulley TJ.
Lam BL, et al. Among authors: pezda m.
Br J Ophthalmol. 2007 May;91(5):585-7. doi: 10.1136/bjo.2006.0107276.
Br J Ophthalmol. 2007.
PMID: 17446504
Free PMC article.
Item in Clipboard
Effectiveness at 1 year of monthly versus variable-dosing intravitreal ranibizumab in the treatment of choroidal neovascularization secondary to age-related macular degeneration.
Katz G, Giavedoni L, Muni R, Evans T, Pezda M, Wong D, Moffat A, Altomare F, Boyd S, Berger A.
Katz G, et al. Among authors: pezda m.
Retina. 2012 Feb;32(2):293-8. doi: 10.1097/IAE.0b013e31821e20b0.
Retina. 2012.
PMID: 21926941
Item in Clipboard
Cite
Cite